Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
COVID-19 vaccination is a life-saving intervention. However, it does not come up without a risk of rare adverse events, which frequency varies between vaccines developed using different technological platforms. The increased risk of Guillain-Barré syndrome (GBS) has been reported for selected adenov...
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Frontiers Media S.A.
2023-04-01
|
| Serie: | Frontiers in Immunology |
| Ämnen: | |
| Länkar: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1183258/full |